BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29718281)

  • 1. Comprehensive Endocrine-Metabolic Evaluation of Patients With Alström Syndrome Compared With BMI-Matched Controls.
    Han JC; Reyes-Capo DP; Liu CY; Reynolds JC; Turkbey E; Turkbey IB; Bryant J; Marshall JD; Naggert JK; Gahl WA; Yanovski JA; Gunay-Aygun M
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2707-2719. PubMed ID: 29718281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome.
    Minton JA; Owen KR; Ricketts CJ; Crabtree N; Shaikh G; Ehtisham S; Porter JR; Carey C; Hodge D; Paisey R; Walker M; Barrett TG
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3110-6. PubMed ID: 16720663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The progression from obesity to type 2 diabetes in Alström syndrome.
    Bettini V; Maffei P; Pagano C; Romano S; Milan G; Favaretto F; Marshall JD; Paisey R; Scolari F; Greggio NA; Tosetto I; Naggert JK; Sicolo N; Vettor R
    Pediatr Diabetes; 2012 Feb; 13(1):59-67. PubMed ID: 21722283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity.
    Dassie F; Favaretto F; Bettini S; Parolin M; Valenti M; Reschke F; Danne T; Vettor R; Milan G; Maffei P
    Endocrine; 2021 Mar; 71(3):618-625. PubMed ID: 33566311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population.
    Mujahid S; Hunt KF; Cheah YS; Forsythe E; Hazlehurst JM; Sparks K; Mohammed S; Tomlinson JW; Amiel SA; Carroll PV; Beales PL; Huda MSB; McGowan BM
    J Clin Endocrinol Metab; 2018 May; 103(5):1834-1841. PubMed ID: 29409041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men.
    Rosmond R; Björntorp P
    Int J Obes Relat Metab Disord; 1998 Dec; 22(12):1184-96. PubMed ID: 9877254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome features presenting in early childhood in Alström syndrome: a case report.
    Pirgon Ö; Atabek ME; Tanju IA
    J Clin Res Pediatr Endocrinol; 2009; 1(6):278-80. PubMed ID: 21274310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association Between Parents History of Type 2 Diabetes with Metabolic Syndrome Component and Insulin Resistance in Non-Diabetic Young Adult Male.
    Aman AM; Rasyid H; Bakri S; Patellongi IJ
    Acta Med Indones; 2018 Oct; 50(4):309-313. PubMed ID: 30630995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance.
    Feuillan PP; Ng D; Han JC; Sapp JC; Wetsch K; Spaulding E; Zheng YC; Caruso RC; Brooks BP; Johnston JJ; Yanovski JA; Biesecker LG
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E528-35. PubMed ID: 21209035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic knockout of alms1 in zebrafish recapitulates Alström syndrome and provides insight into metabolic phenotypes.
    Nesmith JE; Hostelley TL; Leitch CC; Matern MS; Sethna S; McFarland R; Lodh S; Westlake CJ; Hertzano R; Ahmed ZM; Zaghloul NA
    Hum Mol Genet; 2019 Jul; 28(13):2212-2223. PubMed ID: 31220269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis.
    Manco M; Marcellini M; Devito R; Comparcola D; Sartorelli MR; Nobili V
    Int J Obes (Lond); 2008 Feb; 32(2):381-7. PubMed ID: 18087267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic syndrome in overweight and obese schoolchildren in Beijing].
    Wan NJ; Mi J; Wang TY; Duan JL; Li M; Gong CX; Du JB; Zhao XY; Cheng H; Hou DQ; Wang L
    Zhonghua Er Ke Za Zhi; 2007 Jun; 45(6):417-21. PubMed ID: 17880785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
    Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alström syndrome: Renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH clinical center.
    Waldman M; Han JC; Reyes-Capo DP; Bryant J; Carson KA; Turkbey B; Choyke P; Naggert JK; Gahl WA; Marshall JD; Gunay-Aygun M
    Mol Genet Metab; 2018 Sep; 125(1-2):181-191. PubMed ID: 30064963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment and genetic analysis of a case of Alstrom syndrome caused by compoud heterozygous mutation of
    Yang HJ; Li D; Bai HL; Zhang M; Huang J; Yuan XQ
    Yi Chuan; 2022 Dec; 44(12):1148-1157. PubMed ID: 36927560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.